Mildly Elevated Liver Transaminase Levels: Causes and Evaluation.

Area of Science:

• Hepatology
• Primary Care Medicine
• Diagnostic Evaluation

Background:

• Mild, asymptomatic elevations in alanine transaminase (ALT) and aspartate transaminase (AST) affect approximately 10% of the U.S. population.
• Common causes include nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).
• Uncommon and rare causes include drug-induced liver injury, viral hepatitis, hereditary hemochromatosis, alpha1-antitrypsin deficiency, autoimmune hepatitis, and Wilson disease.

Purpose of the Study:

• To outline an efficient clinical approach for evaluating asymptomatic elevations in transaminase levels.
• To guide primary care clinicians in identifying common and serious liver diseases based on prevalence.

Main Methods:

• Initial evaluation includes assessment for metabolic syndrome, complete blood count with platelets, liver function tests, iron studies, and viral hepatitis serologies (Hepatitis C antibody, Hepatitis B surface antigen).
• Utilize the NAFLD fibrosis score and the ALD/NAFLD index for risk stratification.
• Consider hepatic ultrasonography and testing for uncommon causes if initial evaluation is inconclusive or symptoms persist.

Main Results:

• A systematic approach prioritizing common etiologies like NAFLD and ALD is effective.
• Metabolic syndrome and insulin resistance are key factors to assess.
• Lifestyle modification is a primary intervention for suspected NAFLD.

Conclusions:

• A prevalence-based diagnostic strategy aids in the efficient evaluation of elevated transaminases in primary care.
• Early identification and management of NAFLD through lifestyle changes are crucial.
• Further investigation for less common causes is warranted if initial findings are unremarkable or persistent elevations occur.